We are live on ! Find out more
DBG

De Burlo Group Portfolio holdings

AUM $441M
1-Year Est. Return 21.21%
This Fund
S&P 500
This Quarter Est. Return
-7.59%
1 Year Est. Return
+21.21%
3 Year Est. Return
+98.05%
5 Year Est. Return
+220.33%
10 Year Est. Return
+1,846.98%
AUM
$351M
AUM Growth
-$186M
Cap. Flow
-$133M
Cap. Flow %
-37.85%
Top 10 Hldgs %
76.44%
Holding
207
New
37
Increased
22
Reduced
25
Closed
123

Top Buys

Rank Stock Value
1
PG icon
Procter & Gamble
PG
+$35.7M
2
MCK icon
McKesson
MCK
+$33M
3
ELV icon
Elevance Health
ELV
+$28.2M
4
EOG icon
EOG Resources
EOG
+$26.4M
5
NVO
Novo Nordisk
NVO
+$26.2M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$27.1M
2
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$24.3M
3
UNH icon
UnitedHealth
UNH
+$22.6M
4
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$21M
5
MA icon
Mastercard
MA
+$20.4M

Sector Composition

Rank Sector Weight
1 Healthcare 28.18%
2 Consumer Staples 20.19%
3 Technology 15.79%
4 Energy 12.08%
5 Financials 8.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FAST icon
126
Fastenal
FAST
$54B
– –
-4,258
Closed -$126K
FBRT
127
Franklin BSP Realty Trust
FBRT
$601M
– –
-48
Closed -$671
FDX icon
128
FedEx
FDX
$74.5B
– –
-134
Closed -$31K
FISV
129
Fiserv Inc
FISV
$27.2B
– –
-2,063
Closed -$209K
FIS icon
130
Fidelity National Information Services
FIS
$21.5B
– –
-557
Closed -$55.9K
FND icon
131
Floor & Decor
FND
$5.81B
– –
-200
Closed -$16.2K
FSLR icon
132
First Solar
FSLR
$21.8B
– –
-1,600
Closed -$134K
G icon
133
Genpact
G
$5.3B
– –
-400
Closed -$17.4K
GILD icon
134
Gilead Sciences
GILD
$161B
– –
-9,381
Closed -$558K
GIS icon
135
General Mills
GIS
$19.2B
– –
-33,093
Closed -$2.24M
GLD icon
136
SPDR Gold Trust
GLD
$131B
– –
-100
Closed -$18.1K
GSK icon
137
GSK
GSK
$103B
– –
-80
Closed -$4.36K
HELE icon
138
Helen of Troy
HELE
$663M
– –
-100
Closed -$19.6K
HOG icon
139
Harley-Davidson
HOG
$2.68B
– –
-400
Closed -$15.8K
HOLX
140
DELISTED
Hologic
HOLX
– –
-5,400
Closed -$415K
HON icon
141
Honeywell
HON
$77B
– –
-32
Closed -$5.84K
HRB icon
142
H&R Block
HRB
$5.18B
– –
-2,400
Closed -$62.5K
HSIC icon
143
Henry Schein
HSIC
$9.74B
– –
-15,330
Closed -$1.34M
IART icon
144
Integra LifeSciences
IART
$1.54B
– –
-14,463
Closed -$929K
ICE icon
145
Intercontinental Exchange
ICE
$82.4B
– –
-47
Closed -$6.21K
ILMN icon
146
Illumina
ILMN
$29.4B
– –
-8,631
Closed -$2.93M
INDB icon
147
Independent Bank
INDB
$4.05B
– –
-461
Closed -$37.7K
ITW icon
148
Illinois Tool Works
ITW
$81.4B
– –
-6,550
Closed -$1.37M
J icon
149
Jacobs Solutions
J
$15.9B
– –
-86,562
Closed -$9.87M
JPM icon
150
JPMorgan Chase
JPM
$939B
– –
-11,350
Closed -$1.55M
4 5
6
7 8

Similar funds

ECA
Endeavour Capital Advisors Greenwich, Connecticut $441M AUM 21.38% 1-Year Est. Return
DWML
Decker Wealth Management LLC Nashville, Tennessee $441M AUM
BOA
Birnam Oak Advisors New York $441M AUM 37.12% 1-Year Est. Return
PLU
Performa Ltd (US) Charleston, South Carolina $442M AUM 13.84% 1-Year Est. Return
CPW
Cove Private Wealth Oyster Bay Cove, New York $440M AUM 27.56% 1-Year Est. Return
CAAM
Cape Ann Asset Management London, United Kingdom $440M AUM 96.23% 1-Year Est. Return
SCP
SailingStone Capital Partners Houston, Texas $440M AUM 127.21% 1-Year Est. Return
EFMC
Empire Financial Management Company New York $442M AUM 24.42% 1-Year Est. Return

De Burlo Group's Q2 2022 Portfolio in Review

As of Q2 2022, De Burlo Group held 207 positions worth $351M, down 35% from $537M the previous quarter. Its ten largest holdings account for 76% of the portfolio.

De Burlo Group withdrew a net $133M in Q2 2022, closing 123 positions and reducing 25 holdings. Its most notable exit was Regeneron Pharmaceuticals, an estimated $18.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, up from 19% a quarter earlier, followed by Consumer Staples and Technology.

Against the trend, De Burlo Group opened a new position in McKesson worth $33.7M.

  • De Burlo Group's largest Q2 2022 buy was McKesson: 103,170 shares worth $33.7M.
  • De Burlo Group added most to Procter & Gamble in Q2 2022, an estimated $35.7M increase.
  • De Burlo Group's biggest Q2 2022 reduction was Microsoft, cutting an estimated $27.1M.
  • De Burlo Group fully exited Regeneron Pharmaceuticals in Q2 2022, selling an estimated $18.3M.
  • De Burlo Group's ten largest holdings make up 76% of its $351M portfolio in Q2 2022.
  • De Burlo Group opened 37 new positions and closed 123 in Q2 2022.
  • De Burlo Group's portfolio value fell 35% quarter-over-quarter to $351M.

Based on De Burlo Group's 13F filing for Q2 2022, filed 11 Aug 2022.